PRECAINE B BUBBLEGUM- benzocaine topical anesthetic gel
Pascal Company, Inc.
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
----------
Application Directions:
For topical use only
For best results apply to previously dried oral mucosa with cotton swab or similar applicator for adquate control of pain
Removal of excess saliva during application minimizes dilution of the anesthetic and permits maximum penetration
Not more than 1.2mg per Kg body weight per patient should be applied during a 24-hour period
Warning:
Recommended dosage should not be exceeded due to possible side effects.
Keep out of the reach of children.
For professional use only.
Do not use in the eyes.
Avoid swallowing.
Not for home or unsupervised consumer use.
Not for use on children 2 and younger or pregnant or nursing women.
Precaine B is contraindicated in patients with known hypersensitivity to benzocaine or PABA.
PRECAINE B BUBBLEGUM
benzocaine topical anesthetic gel |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Labeler - Pascal Company, Inc. (009260217) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Pascal Company, Inc. | 009260217 | manufacture(10866-0088) |